Ziprasidone may lead to Drug Reaction with Eosinophilia and Systemic Symptoms, reveals IPC drug safety alert - Video
|
Overview
The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of April, has revealed that an atypical antipsychotic Ziprasidone may lead to adverse drug reaction known as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
This came after a preliminary analysis of Adverse Drug Reactions (ADRs) from the Pharmacovigilance Programme of India (PvPI) database.
For more details, check out the link given below:
Drug Safety Alert: Indian Pharmacopoeia Commission Flags ADR Linked To Ziprasidone
Speakers
Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
